Novo Nordisk: shares up after nine-month results
(CercleFinance.com) - Shares in Denmark's Novo Nordisk rose in morning trading on Thursday after the company reported its latest results.
The world's biggest insulin producer said operating profit decreased by 6% in Danish kronor in the first nine months of 2018, on revenues that fell by 2%, mostly due to lower sales in North America.
Sales within diabetes care and obesity decreased by 1%, the company said.
Despite high severance costs related to redundancies made in the third quarter, the company reiterated its full-year guidance.
For 2018, sales growth is expected to be 4-5%, while operating profit growth is still expected to be 2-5%, both measured in local currencies.
By 11:20 this morning, Novo shares were up 2.2% at 291.3 Danish kroner.
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The world's biggest insulin producer said operating profit decreased by 6% in Danish kronor in the first nine months of 2018, on revenues that fell by 2%, mostly due to lower sales in North America.
Sales within diabetes care and obesity decreased by 1%, the company said.
Despite high severance costs related to redundancies made in the third quarter, the company reiterated its full-year guidance.
For 2018, sales growth is expected to be 4-5%, while operating profit growth is still expected to be 2-5%, both measured in local currencies.
By 11:20 this morning, Novo shares were up 2.2% at 291.3 Danish kroner.
Copyright (c) 2018 CercleFinance.com. All rights reserved.